Category: 15. Heart Failure: Clinical
methods: Patients discharged with a primary ICD-9 diagnosis of HF from an Intermountain Healthcare hospital (4/1999-4/2011 ) were studied to test IMRS for all-cause 30dR (N=6616) and to derive a new risk score (IMRS-HF) for 30dR. Recent patients (hospitalized 4/2011-10/2012) validated IMRS-HF (N=459). Age, sex, length of stay, and components of the CBC, BMP, and Charlson Index were evaluated by sex-specific Cox regression for use in IMRS-HF, with beta-coefficients used to assign risk values.
results: IMRS predicted mortality (c=0.70, p<0.001), but was weak for 30dR (c=0.54, p=0.001). In derivation patients, IMRS-HF predicted 30dR for females (n=3461, IMRS-HF range: 0-9) with hazard ratio (HR)=1.22 per +1 score (95% CI=1.16, 1.29; p<0.001) and for males (n=3155, IMRS-HF range: 1-19) with HR=1.25 per +1 score (CI=1.19, 1.31; p<0.001). Highest vs. lowest IMRS-HF groups were substantially stratified (females: HR=5.15 for scores 7-9 [24% 30dR] vs. 0 [5% 30dR]; males: HR=4.47 for 15-19 [22% 30dR] vs. 1-8 [6% 30dR]). C-statistics were c=0.604 (p<0.001) for females and 0.636 (p<0.001) for males. In validation patients, females (n=169) had HR=2.13 (p=0.14) for scores 5-9 (16% 30dR) vs. 0-3 (8% 30dR) and HR=3.37 (p=0.019) for 4 (25% 30dR) vs. 0-3 with c=0.566 (p=0.31), and males (n=290) had HR=8.58 (p=0.041) for scores 15-19 (28% 30dR) vs. 1-8 (4% 30dR) with step-wise risk (HR=1.23 per +1 score, p=0.004; c=0.649, p=0.005).
conclusions: IMRS only weakly predicted 30dR in HF patients. In contrast, 30dR was significantly stratified by IMRS-HF, a new clinical decision tool. IMRS-HF was validated in an independent population, with especially strong findings among males. IMRS-HF may be useful for in-hospital care aimed at preventing readmission and avoiding ACA reimbursement penalties.
